This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| AutoDock | |
|---|---|
| Name | AutoDock |
| Developer | The Scripps Research Institute |
| Released | 1990s |
| Latest release | AutoDock4 / AutoDock Vina |
| Operating system | Cross-platform |
| Programming language | C, C++ |
| License | Various (see Licensing and Distribution) |
AutoDock AutoDock is a widely used computational molecular docking software suite designed for predicting how small molecules, such as ligands and substrates, bind to receptor macromolecules, including proteins, nucleic acids, and membranes. It integrates search algorithms and scoring functions to model binding modes and estimate binding affinities, supporting workflows in structure-based drug design, virtual screening, and computational biophysics. Developed within an academic context, AutoDock has influenced both academic research and pharmaceutical industry pipelines.
AutoDock combines empirical scoring and stochastic search strategies to explore ligand conformational space and receptor interaction sites. It interfaces with molecular structures from repositories like Protein Data Bank and with cheminformatics toolkits such as Open Babel and RDKit for ligand preparation. The suite has been used alongside visualization tools including PyMOL, UCSF Chimera, and VMD to interpret docking poses and map interactions onto structural biology datasets generated by X-ray crystallography, Nuclear Magnetic Resonance, and Cryo-Electron Microscopy. AutoDock workflows often integrate with molecular dynamics packages like GROMACS, AMBER, and NAMD for refinement and rescoring.
AutoDock originated from research groups at institutions such as The Scripps Research Institute and collaborators in computational chemistry and structural biology. Early algorithmic foundations drew on work from algorithm designers at universities including Stanford University and University of California, San Diego, and on optimization methods developed by researchers connected to Los Alamos National Laboratory and Sandia National Laboratories. Funding and collaborative projects involved organizations like the National Institutes of Health, National Science Foundation, and pharmaceutical partners including Pfizer and Merck & Co.. The software evolved through community contributions from academic labs at Massachusetts Institute of Technology, Harvard University, University of Cambridge, and Max Planck Society groups, reflecting advances in computational chemistry, bioinformatics, and high-performance computing from centers such as Argonne National Laboratory and Lawrence Berkeley National Laboratory.
AutoDock implements several search algorithms and scoring paradigms developed from computational chemistry research at institutions like California Institute of Technology and University of Oxford. Key algorithmic components include genetic algorithms inspired by work at University of Michigan, simulated annealing methods linked to developments at IBM Research, and Lamarckian genetic algorithm hybrids influenced by theoretical biology studies at University of Chicago. Scoring functions incorporate empirical potentials and knowledge-based terms paralleling methods used at Columbia University and University of Toronto. AutoDock supports grid-based energy evaluation reminiscent of approaches developed at Los Alamos National Laboratory and integrates torsional sampling strategies explored at Yale University and Princeton University.
The AutoDock ecosystem comprises distinct programs, with lineage traced through software engineering practices at institutions such as Scripps Research, European Molecular Biology Laboratory, and European Bioinformatics Institute. Major branches include iterations optimized for parallel computing frameworks developed with input from Cray Research and Intel Corporation architectures, and enhanced builds leveraging GPU acceleration pioneered by teams at NVIDIA and AMD. Versions have been packaged for package managers maintained by organizations like Debian and Red Hat, with continuous integration practices influenced by platforms like GitHub and GitLab.
AutoDock has been applied across drug discovery projects at companies including Novartis, GlaxoSmithKline, AstraZeneca, and Johnson & Johnson, and in academic studies at University of California, San Francisco and University College London. Use cases span fragment-based design reported in publications from Imperial College London, lead optimization projects at Bayer, and repurposing screens associated with public health efforts tied to World Health Organization and Centers for Disease Control and Prevention. It supports educational initiatives at institutions like University of Cambridge and Massachusetts Institute of Technology and appears in workflows combining cheminformatics from Chemical Abstracts Service and high-throughput screening data from National Center for Advancing Translational Sciences.
Validation studies for AutoDock compare predicted poses and affinities against benchmark datasets curated by consortia such as Protein Data Bank, Community Structure-Activity Resource, and evaluation challenges like those organized by Critical Assessment of protein Structure Prediction and Drug Design Data Resource. Performance assessments reference methodologies developed at Stanford University School of Medicine and statistical frameworks from University of Washington and Johns Hopkins University. Comparative benchmarks contrast AutoDock with docking programs from companies and groups at Schrödinger, BASILISCHE, MOE (Chemical Computing Group), and academic tools emerging from University of Groningen.
AutoDock distribution models reflect licensing practices influenced by academic technology transfer offices at The Scripps Research Institute and industrial partners including Cambridge Enterprise and Stanford Office of Technology Licensing. Releases are disseminated via repositories coordinated with GitHub, package archives managed by institutions such as BioConda and mirrors hosted by European Bioinformatics Institute. Licensing arrangements intersect with open-source frameworks championed by organizations like Free Software Foundation and proprietary negotiation norms observed by companies such as Elsevier and Clarivate Analytics.
Category: Computational chemistry software